Analysis of symptoms and clinical signs of laryngopharyngeal reflux depending on pepsia in saliva

Q4 Medicine Medica Jadertina Pub Date : 2022-08-26 DOI:10.57140/mj.52.2.1
J. Maleš, M. Rezo, I. Abičić, Tihana Mendeš, Andrijana Včeva, Tin Prpić
{"title":"Analysis of symptoms and clinical signs of laryngopharyngeal reflux depending on pepsia in saliva","authors":"J. Maleš, M. Rezo, I. Abičić, Tihana Mendeš, Andrijana Včeva, Tin Prpić","doi":"10.57140/mj.52.2.1","DOIUrl":null,"url":null,"abstract":"In the last fifty years, an epidemic of reflux disease has occurred as a result of poor eating habits, stress, and activities of the food industry. Part of this disease is laryngopharyngeal reflux, a disease characterized by the return of gastric contents to the throat and surrounding organs, leading to hoarseness, coughing, difficulty in swallowing and breathing, and ultimately the development of benign and malignant changes in the larynx. This study is aimed to examine the symptoms and signs of laryngopharyngeal reflux in the study group before and after therapy and to compare the concentration of pepsin in saliva with the above. The prospective longitudinal cohort study included 50 subjects, divided into two groups. The first group consisted of 25 subjects with laryngopharyngeal reflux. The second group consisted of 25 healthy subjects without symptoms and signs of laryngopharyngeal reflux. Symptoms and signs before and after therapy were collected using RSI and RFS questionnaires. Pepsin in saliva was measured with Peptest before and after therapy. The most pronounced symptoms are hoarseness, postnasal drip, and a feeling of \"a lump in the throat\". The median RSI score after three months of therapy was reduced from 20 to 8. From the first group, 7 subjects had measurable levels of pepsin in saliva, and none after therapy. In the control group, no subjects were found to have pepsin in their saliva. Significant improvement was observed in clinical findings (subglottic edema, posterior commissure hypertrophy, vocal cord edema, dense endolaryngeal secretion) after three months of therapy in subjects with LPR. No association of pepsin with LPR symptoms was observed but there is a significant positive association between pepsin and the clinical finding of erythema/hyperemia. In most cases, we start therapy with medication. It is, therefore, important to emphasize that laryngopharyngeal reflux treatment must always begin with a change in diet, lifestyle, and stress regulation. Treatment must be individual and should include a multidisciplinary team with a nutritionist, psychologist, and psychiatrist.","PeriodicalId":39401,"journal":{"name":"Medica Jadertina","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medica Jadertina","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.57140/mj.52.2.1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

In the last fifty years, an epidemic of reflux disease has occurred as a result of poor eating habits, stress, and activities of the food industry. Part of this disease is laryngopharyngeal reflux, a disease characterized by the return of gastric contents to the throat and surrounding organs, leading to hoarseness, coughing, difficulty in swallowing and breathing, and ultimately the development of benign and malignant changes in the larynx. This study is aimed to examine the symptoms and signs of laryngopharyngeal reflux in the study group before and after therapy and to compare the concentration of pepsin in saliva with the above. The prospective longitudinal cohort study included 50 subjects, divided into two groups. The first group consisted of 25 subjects with laryngopharyngeal reflux. The second group consisted of 25 healthy subjects without symptoms and signs of laryngopharyngeal reflux. Symptoms and signs before and after therapy were collected using RSI and RFS questionnaires. Pepsin in saliva was measured with Peptest before and after therapy. The most pronounced symptoms are hoarseness, postnasal drip, and a feeling of "a lump in the throat". The median RSI score after three months of therapy was reduced from 20 to 8. From the first group, 7 subjects had measurable levels of pepsin in saliva, and none after therapy. In the control group, no subjects were found to have pepsin in their saliva. Significant improvement was observed in clinical findings (subglottic edema, posterior commissure hypertrophy, vocal cord edema, dense endolaryngeal secretion) after three months of therapy in subjects with LPR. No association of pepsin with LPR symptoms was observed but there is a significant positive association between pepsin and the clinical finding of erythema/hyperemia. In most cases, we start therapy with medication. It is, therefore, important to emphasize that laryngopharyngeal reflux treatment must always begin with a change in diet, lifestyle, and stress regulation. Treatment must be individual and should include a multidisciplinary team with a nutritionist, psychologist, and psychiatrist.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
唾液中胃蛋白酶对咽喉反流症状和临床体征的影响
在过去的五十年里,由于不良的饮食习惯、压力和食品行业的活动,反流病的流行已经发生。这种疾病的一部分是喉咽反流,这种疾病的特点是胃内容物回流到喉咙和周围器官,导致声音嘶哑、咳嗽、吞咽和呼吸困难,并最终发展为喉部的良性和恶性变化。本研究旨在检查研究组在治疗前后的咽喉反流症状和体征,并将唾液中胃蛋白酶的浓度与上述浓度进行比较。前瞻性纵向队列研究包括50名受试者,分为两组。第一组由25名患有咽喉反流的受试者组成。第二组由25名没有咽喉反流症状和体征的健康受试者组成。使用RSI和RFS问卷收集治疗前后的症状和体征。在治疗前后用Peptist测定唾液中的胃蛋白酶。最明显的症状是声音嘶哑、鼻后滴漏和“喉咙哽咽”的感觉。治疗三个月后,RSI评分中位数从20分降至8分。第一组中,7名受试者唾液中胃蛋白酶水平可测量,治疗后无一例。在对照组中,没有发现受试者的唾液中含有胃蛋白酶。LPR受试者治疗三个月后,临床表现(声门下水肿、后连合肥大、声带水肿、喉内分泌物密集)显著改善。没有观察到胃蛋白酶与LPR症状的相关性,但胃蛋白酶与红斑/充血的临床发现之间存在显著的正相关性。在大多数情况下,我们从药物治疗开始。因此,需要强调的是,咽喉反流治疗必须始终从改变饮食、生活方式和压力调节开始。治疗必须是个性化的,应该包括一个由营养学家、心理学家和精神病学家组成的多学科团队。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Medica Jadertina
Medica Jadertina Medicine-Medicine (all)
CiteScore
0.10
自引率
0.00%
发文量
38
期刊介绍: Medica Jadertina magazine contains scientific and professional papers covering a wide range of themes in the fields of biomedicine and health, psychology, pharmaceutics, public health and health insurance. Scientific areas: Biomedicine and health; Public health and health care; Pharmaceutics; Psychology.
期刊最新文献
Prediktori depresije kod učenika osmih razreda Požeško-slavonske županije Dexamethasone treatment in chronic subdural hematoma - a case report Pregnancy complicated by small cell neuroendocrine carcinoma of the cervix The diversity of measures proscribed measures for offenders with mental health issues Detekcija dobrovoljnog darivatelja krvi s preboljelom infekcijom hepatitisa Bprikaz bolesnice
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1